NEW YORK (GenomeWeb News) – Gene Express today said that it has signed a definitive agreement to collaborate with AbaStar MDx on the development of biomarker tests for neurological and psychological disorders.

Under the agreement, AbaStar has licensed Gene Express’ SEM Center and StaRT-PCR technology. It will combine the PCR technology with its own RNA biomarker signatures to develop diagnostic tests that run from a blood sample and provide results in a day.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.